
भारतात GLP-1 पर वैद्य से कसे बात करें
15-minute consultation prepared जाने पर आगे। T2D, obesity, both—frameworks partner, prescription demand नाही. Doctor time, duplicate tests कम, titration/cost/long-term OOP expectations। NMC, CDSCO pharmacy, follow-up before first injection।
Short answer
HbA1c, lipids, kidney/liver, weight history, medicines लाएँ। Indications, titration, side effects, cost, monitoring पूछें। Drug-class conversation, brand demand नाही. Budget early। Follow-up schedule। Kesho education—NMC doctor Schedule H। Online बिना prescription नाही.
Key takeaways
- •Organised labs, weight history, full medicines including ayurvedic supplements limited consultation maximise।
- •GLP-1 drug-class conversation (semaglutide, tirzepatide, other RA) not social media brand demand।
- •Explicit ask titration, nausea, monitoring labs, monthly cost, urgent symptoms contact।
- •Monthly medication budget early discuss—India OOP adherence/outcomes affordability drives।
- •Licensed pharmacy CDSCO-approved fill only; clinic leave follow-up schedule before।
GLP-1 therapy India कौन doctor?
Endocrinologist, internal medicine specialist, cardiologist incretin experienced—already manages diabetes/obesity/CVR। Complex obesity polypharmacy thyroid insulin endocrinology। Tier-2 teleconsult metro specialist local monitoring common। NMC registered verify। Guaranteed prescription brief online form platforms avoid—ethical proper evaluation। PCOS fatty liver CVD upfront coordinate specialties। RSSDI glycaemic unmet GLP-1; obesity-only ICMR South Asian BMI thresholds।
India GLP-1 therapy typically कौन manage?
- Provider: Diabetologist/endocrinologist — Best: Initiation titration complex — Limitation: Metro wait longer
- Provider: General physician — Best: Straightforward stable T2D — Limitation: Obesity-only/MEN2 refer
- Provider: Teleconsult specialist — Best: Tier-2 access second opinion — Limitation: Local lab injection support
- Provider: Unverified online sellers — Best: None avoid — Limitation: Illegal Schedule H counterfeit
Records/information काय bring?
Recent HbA1c (<3 months), fasting/post-prandial glucose, lipids, liver/kidney, thyroid, fatty liver ultrasound। Weight log, all medicines ayurvedic supplements, family diabetes/thyroid cancer/pancreatitis, prior diet/weight attempts। Allergies injection phobia। Online research questions not demands। Drug-class language (semaglutide, tirzepatide, liraglutide) not brand slogans appreciated। One-page self summary > unrelated report stack।
Goal partnership phrase: "मैंने T2D/weight GLP-1 RA पढ़ा। HbA1c 8.1 BMI 28—काय यह class मेरे लिए उपयुक्त discuss कर सकते?"
Essential questions doctor?
Candidate BMI/HbA1c/comorbidities? Molecule fit semaglutide/tirzepatide/other RA? Titration schedule nausea manage? Monitoring labs how often? Monthly cost generic? How long continue? Travel/missed dose? Current diabetes meds adjusted? Lifestyle targets? Urgent symptoms? Answers write—memory fades। Side effects between appointments contact: nurse, WhatsApp triage, emergency?
Consultation checklist: questions why matter
- Question: Eligible? — Why: ICMR/RSSDI thresholds Western calculators differ
- Question: Molecule route? — Why: Oral vs injectable cost adherence
- Question: Titration plan? — Why: Rush nausea drop-out
- Question: Monthly cost? — Why: OOP affordability India adherence
- Question: Monitoring? — Why: HbA1c kidney thyroid indicated
- Question: Emergency symptoms? — Why: Pancreatitis severe GI clear rules
Honest cost conversation कसे?
Indian doctors sometimes under-discuss cost until unable refill। Monthly budget openly ₹8,000 vs ₹20,000 viable options change। Generic semaglutide titration spread costs oral vs injectable wallet। Limited affordability intensive lifestyle/older cheaper GLP-1 RAs discuss। Abrupt stop wastes progress day one planning। Employer insurance/CGHS diabetes GLP-1 written confirmation not HR verbal। Intermittent dosing force say so—doctor may recommend not start sub-therapeutic।
Safety/monitoring topics cover?
Personal/family MTC, MEN2, pancreatitis, gallbladder, severe GI history discuss। GLP-1 current meds especially sulfonylurea/insulin hypoglycaemia। Pregnancy plans clarify—not pregnancy use। Diabetic retinopathy rapid glucose ophthalmology if existing retinopathy। CDSCO class warnings every approved product not one brand। Written aftercare injection technique Indian heat storage travel request। Safety not scare—when call vs persist mild nausea recognise।

Medically reviewed
Dr. Ananya Mehta, MD, DM Endocrinology
Consultant Endocrinologist, India
This article has been reviewed by our medical advisory team, including endocrinologists, internal medicine specialists, and cardiologists, and is based on current scientific evidence and Indian clinical guidelines. Last reviewed: June 2026.
Last medically reviewed: Jun 26, 2026